Literature DB >> 12803499

The role of growth factors on renal tubular cells submitted to hypoxia and deprived of glucose.

Marcelino de Souza Durão1, Clara Versolato Razvickas, Elsa Alídia Petry Gonçalves, Iria Ruriko Okano, Simone Mafalda Rodrigues Camargo, Júlio Cesar Martins Monte, Oscar Fernando Pavão dos Santos.   

Abstract

BACKGROUND: In acute renal failure (ARF) renal tubular cell death and detachment can be induced by necrotic and apoptotic mechanisms. Several studies have demonstrated some benefits of the use of growth factors in experimental models of ARF.
METHODS: MDCK cells were cultured in a glucose-free medium for 24h and were submitted to hypoxia (PO2 around 35 mmHg) for additional 24 h. To evaluate the possible protective role of growth factors, EGF, IGF-I or HGF were added to the medium (20 ng mL). LDH release, viability (acridine orange and ethidium bromide dyes) and quantification of apoptotic cells (Hoechst 33342 dye fluorescence) were determined.
RESULTS: In the injury group, an increase on LDH release (60% vs. 3%) and on number of apoptotic cells (22% vs. 0.2%) which was associated with a reduced cell viability (61% vs. 94%) when compared with controls. Only HGF, not EGF or IGF-I, was able to protect cells from injury. HGF caused a significant reduction on LDH release (30%) and on number of apoptotic cells (5%), with an increase on viability cellular (79%).
CONCLUSIONS: HGF decreases cell death on MDCK cells after hypoxic-induced injury, probably acting in both necrotic and apoptotic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12803499     DOI: 10.1081/jdi-120021149

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

1.  Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

2.  Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery-Associated Acute Kidney Injury.

Authors:  Sabry Ayad; John F Neylan; Tracy J Mayne; Deborah Gouveia; Madhav Swaminathan
Journal:  Kidney Int Rep       Date:  2020-09-25

3.  Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-γ Activation and Subsequent Regulation of TGF-β1 and HGF Expression.

Authors:  Ya-Dong Liu; Shi-Liang Yu; Rui Wang; Jian-Nan Liu; Yin-Shan Jin; Yi-Fu Li; Rui-Hua An
Journal:  Oxid Med Cell Longev       Date:  2019-11-12       Impact factor: 6.543

4.  Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function.

Authors:  Flavio Vincenti; Jim Kim; Deborah Gouveia; Gabrielle Pelle; Tracy J Mayne; John F Neylan
Journal:  Kidney Int Rep       Date:  2020-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.